Outlines a study by Barbara Smith, et al, reported in `Lancet' that used reverse transcriptase to make complementary DNA from peripheral blood messenger RNA, and the polymerase chain reaction (PCR) to amplify cDNA specific for a gene actively transcribed only in the tumor tissue type. Patients with malignant melanoma, other metastatic cancers and healthy subjects; Details.